Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor

Abstract Erythropoietin (EPO) has protective effects in neurodegenerative and neuroinflammatory diseases, including in animal models of multiple sclerosis, where EPO decreases disease severity. EPO also promotes neurogenesis and is protective in models of toxic demyelination. In this study, we asked...

Full description

Saved in:
Bibliographic Details
Main Authors: Ilaria Cervellini (Author), Alexander Annenkov (Author), Thomas Brenton (Author), Yuti Chernajovsky (Author), Pietro Ghezzi (Author), Manuela Mengozzi (Author)
Format: Book
Published: BMC, 2013-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c7dcda4a3fa74e23bde0e4b6059b0fd9
042 |a dc 
100 1 0 |a Ilaria Cervellini  |e author 
700 1 0 |a Alexander Annenkov  |e author 
700 1 0 |a Thomas Brenton  |e author 
700 1 0 |a Yuti Chernajovsky  |e author 
700 1 0 |a Pietro Ghezzi  |e author 
700 1 0 |a Manuela Mengozzi  |e author 
245 0 0 |a Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor 
260 |b BMC,   |c 2013-06-01T00:00:00Z. 
500 |a 10.2119/molmed.2013.00013 
500 |a 1076-1551 
500 |a 1528-3658 
520 |a Abstract Erythropoietin (EPO) has protective effects in neurodegenerative and neuroinflammatory diseases, including in animal models of multiple sclerosis, where EPO decreases disease severity. EPO also promotes neurogenesis and is protective in models of toxic demyelination. In this study, we asked whether EPO could promote neurorepair by also inducing remyelination. In addition, we investigated whether the effect of EPO could be mediated by the classical erythropoietic EPO receptor (EPOR), since it is still questioned if EPOR is functional in nonhematopoietic cells. Using CG4 cells, a line of rat oligodendrocyte precursor cells, we found that EPO increases the expression of myelin genes (myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP)). EPO had no effect in wild-type CG4 cells, which do not express EPOR, whereas it increased MOG and MBP expression in cells engineered to overexpress EPOR (CG4-EPOR). This was reflected in a marked increase in MOG protein levels, as detected by Western blot. In these cells, EPO induced by 10-fold the early growth response gene 2 (Egr2), which is required for peripheral myelination. However, Egr2 silencing with a siRNA did not reverse the effect of EPO, indicating that EPO acts through other pathways. In conclusion, EPO induces the expression of myelin genes in oligodendrocytes and this effect requires the presence of EPOR. This study demonstrates that EPOR can mediate neuroreparative effects. 
546 |a EN 
690 |a Myelin Gene 
690 |a Medulla 
690 |a Early Growth Response Gene 
690 |a Myelin Oligodendrocyte Glycoprotein (MOG) 
690 |a Myelin Basic Protein (MBP) 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Biochemistry 
690 |a QD415-436 
655 7 |a article  |2 local 
786 0 |n Molecular Medicine, Vol 19, Iss 1, Pp 223-229 (2013) 
787 0 |n https://doi.org/10.2119/molmed.2013.00013 
787 0 |n https://doaj.org/toc/1076-1551 
787 0 |n https://doaj.org/toc/1528-3658 
856 4 1 |u https://doaj.org/article/c7dcda4a3fa74e23bde0e4b6059b0fd9  |z Connect to this object online.